The link between ISO 13485 FDA QMSR became far closer in 2024. The FDA replaced its old Quality System Regulation (QSR) with the Quality Management System Regulation (QMSR), which incorporates ISO 13485 by reference. Understanding ISO 13485 FDA QMSR alignment now matters for any manufacturer selling in the US, because your ISO 13485 system is increasingly the basis for FDA compliance too.
From QSR to QMSR
The FDA finalized the Quality Management System Regulation (QMSR), which incorporates ISO 13485:2016 by reference and replaces the previous Quality System Regulation. Published in early 2024 with a two-year transition, the QMSR took effect in February 2026. In practice, US quality-system requirements are now built directly on the international standard.
What this means for you
- Harmonization. The US requirements now share a common backbone with the rest of the world, reducing the old duplication between “the FDA way” and “the ISO way.”
- ISO 13485 is now central to US compliance, not just international market access.
- Less parallel documentation. Companies previously maintaining separate QSR and ISO 13485 systems can converge on one.
One QMS, two markets.
Because the FDA’s QMSR is built on ISO 13485, a strong 13485 quality system is now your foundation for both US and international compliance. The ISO 13485 Toolkit gives you that foundation, ready to tailor.
It’s not a perfect one-to-one
Importantly, the QMSR incorporates ISO 13485 by reference but layers some FDA-specific requirements on top — including certain definitions and additional records and controls that reflect US law (for example, expectations around labeling and unique device identification). So “ISO 13485 certified” is the foundation, but US manufacturers still need to meet the FDA’s additional provisions.
Important: Regulations change and the details are nuanced. Confirm the current QMSR requirements and effective-date specifics against the FDA’s official guidance, and consult a regulatory professional for your situation.
The practical takeaway
If you’re building or maintaining a medical-device QMS today, ISO 13485 is the right foundation for both international and US compliance. Getting your 13485 system right — then adding the FDA’s specific requirements — is far more efficient than running two separate systems. See our certification process guide for how to build it.
What ISO 13485 FDA QMSR alignment means for you
Under the QMSR, which takes effect in February 2026, the FDA aligns its quality-system expectations with ISO 13485 rather than maintaining a separate US-only rulebook. For manufacturers already certified to ISO 13485, this is largely good news: much of what you do already maps to FDA expectations, reducing duplicate systems. It is not a perfect one-to-one, though — the QMSR adds US-specific requirements and definitions on top of the standard, so ISO 13485 FDA QMSR alignment narrows the gap without eliminating it. Confirm the current rule text with the FDA; this article is general information, not regulatory advice.
Frequently asked questions
Does ISO 13485 certification make me QMSR-compliant automatically?
No — it’s the foundation, but the QMSR adds FDA-specific requirements you must also meet. Certification and regulatory compliance are related but distinct.
When did the QMSR take effect?
February 2026, following a two-year transition from the final rule. Always verify the current status with the FDA.
This article is general information, not legal or regulatory advice. Consult a qualified professional about your specific obligations.
New to the standard? Start with our complete guide to ISO 13485.
The practical takeaway: build a strong ISO 13485 system and you are well positioned for the QMSR — but treat the US-specific additions as their own workstream and verify the effective dates and details with the FDA for your device.